Skip to main content
NCBI home page
Transactions of the American Ophthalmological Society logoLink to Transactions of the American Ophthalmological Society
. 1980;78:846–895.

Chemotherapy of experimental endogenous Candida albicans endophthalmitis.

D B Jones
PMCID: PMC1312161  PMID: 6266113

Full text

PDF
846

Images in this article

853FIGURE 2 A
on p.853
853FIGURE 2 B
on p.853
853FIGURE 2 C
on p.853
853FIGURE 2 D
on p.853
853FIGURE 2 E
on p.853
853FIGURE 2 F
on p.853
854FIGURE 3
on p.854
855FIGURE 4
on p.855
862FIGURE 8
on p.862
863FIGURE 9 A
on p.863
863FIGURE 9 B
on p.863
863FIGURE 9 C
on p.863
863FIGURE 9 D
on p.863

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDRIOLE V. T., KRAVETZ H. M., ROBERTS W. C., UTZ J. P. Candida endocarditis. Clinical and pathologic studies. Am J Med. 1962 Feb;32:251–285. doi: 10.1016/0002-9343(62)90294-2. [DOI] [PubMed] [Google Scholar]
  2. Athar M. A., Winner H. I. The development of resistance by candida species to polyene antibiotics in vitro. J Med Microbiol. 1971 Nov;4(4):505–517. doi: 10.1099/00222615-4-4-505. [DOI] [PubMed] [Google Scholar]
  3. Axelrod A. J., Peyman G. A. Intravitreal amphotericin B treatment of experimental fungal endophthalmitis. Am J Ophthalmol. 1973 Oct;76(4):584–588. doi: 10.1016/0002-9394(73)90754-x. [DOI] [PubMed] [Google Scholar]
  4. Baine W. B., Koenig M. G., Goodman J. S. Clearance of Candida albicans from the bloodstream of rabbits. Infect Immun. 1974 Dec;10(6):1420–1425. doi: 10.1128/iai.10.6.1420-1425.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Balandran L., Rothschild H., Pugh N., Seabury J. A cutaneous manifestation of systemic candidiasis. Ann Intern Med. 1973 Mar;78(3):400–403. doi: 10.7326/0003-4819-78-3-400. [DOI] [PubMed] [Google Scholar]
  6. Bennet J. E. Flucytosine. Ann Intern Med. 1977 Mar;86(3):319–321. doi: 10.7326/0003-4819-86-3-319. [DOI] [PubMed] [Google Scholar]
  7. Bennett J. E., Dismukes W. E., Duma R. J., Medoff G., Sande M. A., Gallis H., Leonard J., Fields B. T., Bradshaw M., Haywood H. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med. 1979 Jul 19;301(3):126–131. doi: 10.1056/NEJM197907193010303. [DOI] [PubMed] [Google Scholar]
  8. Bernhardt H. E., Orlando J. C., Benfield J. R., Hirose F. M., Foos R. Y. Disseminated candidiasis in surgical patients. Surg Gynecol Obstet. 1972 May;134(5):819–825. [PubMed] [Google Scholar]
  9. Bindschadler D. D., Bennett J. E. A pharmacologic guide to the clinical use of amphotericin B. J Infect Dis. 1969 Oct;120(4):427–436. doi: 10.1093/infdis/120.4.427. [DOI] [PubMed] [Google Scholar]
  10. Bodey G. P. Fungal infections complicating acute leukemia. J Chronic Dis. 1966 Jun;19(6):667–687. doi: 10.1016/0021-9681(66)90066-x. [DOI] [PubMed] [Google Scholar]
  11. Bodey G. P., Luna M. Skin lesions associated with disseminated candidiasis. JAMA. 1974 Sep 9;229(11):1466–1468. [PubMed] [Google Scholar]
  12. Bonner D. P., Tewari R. P., Solotorovsky M., Mechlinski W., Schaffner C. P. Comparative chemotherapeutic activity of amphotericin B and amphotericine B methy ester. Antimicrob Agents Chemother. 1975 Jun;7(6):724–729. doi: 10.1128/aac.7.6.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Brennan M. F., Goldman M. H., O'Connell R. C., Kundsin R. B., Moore F. D. Prolonged parenteral alimentation: Candida growth and the prevention of candidemia by amphotericin instillation. Ann Surg. 1972 Sep;176(3):265–272. doi: 10.1097/00000658-197209000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cohen M., Edwards J. E., Jr, Hensley T. J., Guze L. B. Experimental hematogenous Candida albicans endophthalmitis: electron microscopy. Invest Ophthalmol Vis Sci. 1977 Jun;16(6):498–511. [PubMed] [Google Scholar]
  15. Cushman A. R., Friedman G., Capsavage J. Systemic candidiasis and endophthalmitis in neurosurgical patients. Report of three cases. J Neurosurg. 1976 Jul;45(1):95–97. doi: 10.3171/jns.1976.45.1.0095. [DOI] [PubMed] [Google Scholar]
  16. Cutler J. E., Friedman L., Milner K. C. Biological and chemical characterization of toxic substances from Candida albicans. Infect Immun. 1972 Oct;6(4):616–627. doi: 10.1128/iai.6.4.616-627.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. De Nollin S., Borgers M., Van Belle H. The effects of miconazole on the ultrastructure of Candida albicans. Proc R Soc Med. 1977;70 (Suppl 4):19–23. doi: 10.1177/00359157770700S406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dellon A. L., Stark W. J., Chretien P. B. Spontaneous resolution of endogenous Candida endophthalmitis complicating intravenous hyperalimentation. Am J Ophthalmol. 1975 Apr;79(4):648–654. doi: 10.1016/0002-9394(75)90805-3. [DOI] [PubMed] [Google Scholar]
  19. Demant E., Easterbrook M. An experimental model of candida endophthalmitis. Can J Ophthalmol. 1977 Oct;12(4):304–307. [PubMed] [Google Scholar]
  20. Demierre G., Freedman L. R. Experimental endocarditis: prophylaxis of Candida albicans infections by 5-fluorocytosine in rabbits. Antimicrob Agents Chemother. 1979 Sep;16(3):252–254. doi: 10.1128/aac.16.3.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Diasio R. B., Lakings D. E., Bennett J. E. Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity. Antimicrob Agents Chemother. 1978 Dec;14(6):903–908. doi: 10.1128/aac.14.6.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Dixon D., Shadomy S., Shadomy H. J., Espinel-Ingroff A., Kerkering T. M. Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400. J Infect Dis. 1978 Aug;138(2):245–248. doi: 10.1093/infdis/138.2.245. [DOI] [PubMed] [Google Scholar]
  23. Edwards J. E., Jr, Foos R. Y., Montgomerie J. Z., Guze L. B. Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis. Medicine (Baltimore) 1974 Jan;53(1):47–75. doi: 10.1097/00005792-197401000-00002. [DOI] [PubMed] [Google Scholar]
  24. Edwards J. E., Jr, Lehrer R. I., Stiehm E. R., Fischer T. J., Young L. S. Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med. 1978 Jul;89(1):91–106. doi: 10.7326/0003-4819-89-1-91. [DOI] [PubMed] [Google Scholar]
  25. Edwards J. E., Jr, Montgomerie J. Z., Foos R. Y., Shaw V. K., Guze L. B. Experimental hematogenous endophthalmitis caused by Candida albicans. J Infect Dis. 1975 Jun;131(6):649–657. doi: 10.1093/infdis/131.6.649. [DOI] [PubMed] [Google Scholar]
  26. Edwards J. E., Jr, Montgomerie J. Z., Ishida K., Morrison J. O., Guze L. B. Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity. J Infect Dis. 1977 Feb;135(2):294–297. doi: 10.1093/infdis/135.2.294. [DOI] [PubMed] [Google Scholar]
  27. Edwards J. E., Turkel S. B., Elder H. A., Rand R. W., Guze L. B. Hematogenous candida osteomyelitis. Report of three cases and review of the literature. Am J Med. 1975 Jul;59(1):89–94. doi: 10.1016/0002-9343(75)90325-3. [DOI] [PubMed] [Google Scholar]
  28. Elliott J. H., O'Day D. M., Gutow G. S., Podgorski S. F., Akrabawi P. Mycotic endophthalmitis in drug abusers. Am J Ophthalmol. 1979 Jul;88(1):66–72. doi: 10.1016/0002-9394(79)90757-8. [DOI] [PubMed] [Google Scholar]
  29. Eras P., Goldstein M. J., Sherlock P. Candida infection of the gastrointestinal tract. Medicine (Baltimore) 1972 Sep;51(5):367–379. doi: 10.1097/00005792-197209000-00002. [DOI] [PubMed] [Google Scholar]
  30. Ezdinli E. Z., O'Sullivan D. D., Wasser L. P., Kim U., Stutzman L. Oral amphotericin for candidiasis in patients with hematologic neoplasms. An autopsy study. JAMA. 1979 Jul 20;242(3):258–260. [PubMed] [Google Scholar]
  31. Filice G., Yu B., Armstrong D. Immunodiffusion and agglutination tests for Candida in patients with neoplastic disease: inconsistent correlation of results with invasive infections. J Infect Dis. 1977 Mar;135(3):349–357. doi: 10.1093/infdis/135.3.349. [DOI] [PubMed] [Google Scholar]
  32. Fisher J. F., Duma R. J., Markowitz S. M., Shadomy S., Espinel-Ingroff A., Chew W. H. Therapeutic failures with miconazole. Antimicrob Agents Chemother. 1978 Jun;13(6):965–968. doi: 10.1128/aac.13.6.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Folb P. I., Trounce J. R. Immunological aspects of candida infection complicating steroid and immunosuppressive drug therapy. Lancet. 1970 Nov 28;2(7683):1112–1114. doi: 10.1016/s0140-6736(70)92299-3. [DOI] [PubMed] [Google Scholar]
  34. Forster R. K. Endophthalmitis. Diagnostic cultures and visual results. Arch Ophthalmol. 1974 Nov;92(5):387–392. doi: 10.1001/archopht.1974.01010010399005. [DOI] [PubMed] [Google Scholar]
  35. Foster C. S., Stefanyszyn M. Intraocular penetration of miconazole in rabbits. Arch Ophthalmol. 1979 Sep;97(9):1703–1706. doi: 10.1001/archopht.1979.01020020271017. [DOI] [PubMed] [Google Scholar]
  36. Freeman J. B., Davis P. L., MacLean L. D. Candida endophthalmitis associated with intravenous hyperalimentation. Arch Surg. 1974 Feb;108(2):237–240. doi: 10.1001/archsurg.1974.01350260089022. [DOI] [PubMed] [Google Scholar]
  37. Freund J., Rüger K., Malchow H. Metastatische Ophthalmie nach Candidasepsis. Erfahrungen mit dem neuen oralen Antimykotikum Bay b 5097. Klin Monbl Augenheilkd. 1972 Jul;161(1):82–88. [PubMed] [Google Scholar]
  38. GREEN W. R., BENNETT J. E., GOOS R. D. OCULAR PENETRATION OF AMPHOTERICIN B: A REPORT OF LABORATORY STUDIES AND A CASE REPORT OF POSTSURGICAL CEPHALOSPORIUM ENDOPHTHALMITIS. Arch Ophthalmol. 1965 Jun;73:769–775. doi: 10.1001/archopht.1965.00970030771004. [DOI] [PubMed] [Google Scholar]
  39. Gadebusch H. H., Pansy F., Klepner C., Schwind R. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice. J Infect Dis. 1976 Nov;134(5):423–427. doi: 10.1093/infdis/134.5.423. [DOI] [PubMed] [Google Scholar]
  40. Getnick R. A., Rodrigues M. M. Endogenous fungal endophthalmitis in a drug addict. Am J Ophthalmol. 1974 May;77(5):680–683. doi: 10.1016/0002-9394(74)90531-5. [DOI] [PubMed] [Google Scholar]
  41. Griffin J. R., Pettit T. H., Fishman L. S., Foos R. Y. Blood-borne Candida endophthalmitis. A clinical and pathologic study of 21 cases. Arch Ophthalmol. 1973 Jun;89(6):450–456. doi: 10.1001/archopht.1973.01000040452002. [DOI] [PubMed] [Google Scholar]
  42. HASENCLEVER H. F. Comparative pathogenicity of Candida albicans for mice and rabbits. J Bacteriol. 1959 Jul;78(1):105–109. doi: 10.1128/jb.78.1.105-109.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. HOFFMAN D. H., WAUBKE T. [Experimental studies on metastatic ophthalmia with Candida albicans]. Albrecht Von Graefes Arch Ophthalmol. 1961;164:174–196. doi: 10.1007/BF00682391. [DOI] [PubMed] [Google Scholar]
  44. Henderson D. K., Edwards J. E., Jr, Ishida K., Guze L. B. Experimental hematogenous Candida endophthalmitis: diagnostic approaches. Infect Immun. 1979 Mar;23(3):858–862. doi: 10.1128/iai.23.3.858-862.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Hoffmann D. H. Die experimentelle endogene Entzündung des Augeninnrn durch Candida albicans. Ophthalmoskopische, histologische und mikrobiologische Studien zum Ablau der Infektion beim Kaninchen. Ophthalmologica. 1966;151:1–84. doi: 10.1159/000304878. [DOI] [PubMed] [Google Scholar]
  46. Howarth W. R., Tewari R. P., Solotorovsky M. Comparative in vitro antifungal activity of amphotericin B and amphotericin B methyl ester. Antimicrob Agents Chemother. 1975 Jan;7(1):58–63. doi: 10.1128/aac.7.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Howes E. L., Jr, Cruse V. K. The structural basis of altered vascular permeability following intraocular inflammation. Arch Ophthalmol. 1978 Sep;96(9):1668–1676. doi: 10.1001/archopht.1978.03910060294024. [DOI] [PubMed] [Google Scholar]
  48. Howlett J. A. The infection of rat tongue mucosa in vitro with five species of Candida. J Med Microbiol. 1976 Aug;9(3):309–316. doi: 10.1099/00222615-9-3-309. [DOI] [PubMed] [Google Scholar]
  49. Huang K., Peyman G. A., McGetrick J. Vitrectomy in experimental endophthalmitis: Part I-Fungal infection. Ophthalmic Surg. 1979 Mar;10(3):84–86. [PubMed] [Google Scholar]
  50. Hughes J. M., Remington J. S. Systemic candidiasis, a diagnostic challenge. Calif Med. 1972 Jun;116(6):8–17. [PMC free article] [PubMed] [Google Scholar]
  51. Huston A. C., Hoeprich P. D. Comparative susceptibility of four kinds of pathogenic fungi to amphotericin B and amphotericin B methyl ester. Antimicrob Agents Chemother. 1978 Jun;13(6):905–909. doi: 10.1128/aac.13.6.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Hvidberg-Hansen A. Endogenous mycotic retinopathy. Report of a case. Acta Ophthalmol (Copenh) 1972;50(4):515–519. doi: 10.1111/j.1755-3768.1972.tb05977.x. [DOI] [PubMed] [Google Scholar]
  53. Iannini P. B., Arai G. D., LaForce F. M. Vascular clearance of blastospore and pseudomycelial phase Candida albicans. Sabouraudia. 1977 Jul;15(2):201–205. [PubMed] [Google Scholar]
  54. Imbeau S. A., Hanson J., Langejans G., D'Alessio D. Flucytosine treatment of Candida arthritis. JAMA. 1977 Sep 26;238(13):1395–1396. [PubMed] [Google Scholar]
  55. JAMSHIDI A., POPE R. H., FRIEDMAN N. H. FUNGAL ENDOCARDITIS COMPLICATING CARDIAC SURGERY. Arch Intern Med. 1963 Sep;112:370–376. doi: 10.1001/archinte.1963.03860030124013. [DOI] [PubMed] [Google Scholar]
  56. Jones B. R. Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture. Am J Ophthalmol. 1975 May;79(5):719–751. doi: 10.1016/0002-9394(75)90730-8. [DOI] [PubMed] [Google Scholar]
  57. Kay J. H., Berstein S., Tsuji H. K., Redington J. V., Milgram M., Brem T. Surgical treatment of candida endocarditis. JAMA. 1968 Feb 26;203(9):621–626. [PubMed] [Google Scholar]
  58. Keim G. R., Jr, Poutsiaka J. W., Kirpan J., Keysser C. H. Amphotericin B methyl ester hydrochloride and amphotericin B: comparative acute toxicity. Science. 1973 Feb 9;179(4073):584–585. doi: 10.1126/science.179.4073.584. [DOI] [PubMed] [Google Scholar]
  59. Koechlin B. A., Rubio F., Palmer S., Gabriel T., Duschinsky R. The metabolism of 5-fluorocytosine-2-14-C and of cytosine-14-C in the rat and the disposition of 5-fluorocytosine-2-14-C in man. Biochem Pharmacol. 1966 Apr;15(4):435–446. doi: 10.1016/0006-2952(66)90254-1. [DOI] [PubMed] [Google Scholar]
  60. Krause W., Matheis H., Wulf K. Fungaemia and funguria after oral administration of Candida albicans. Lancet. 1969 Mar 22;1(7595):598–599. doi: 10.1016/s0140-6736(69)91534-7. [DOI] [PubMed] [Google Scholar]
  61. Krick J. A., Remington J. S. Opportunistic invasive fungal infections in patients with leukaemia lymphoma. Clin Haematol. 1976 Jun;5(2):249–310. [PubMed] [Google Scholar]
  62. Kwan C. N., Medoff G., Kobayashi G. S., Schlessinger D., Raskas H. J. Potentiation of the antifungal effects of antibiotics by amphotericin B. Antimicrob Agents Chemother. 1972 Aug;2(2):61–65. doi: 10.1128/aac.2.2.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Lawrence R. M., Hoeprich P. D. Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis and toxicity. J Infect Dis. 1976 Feb;133(2):168–174. doi: 10.1093/infdis/133.2.168. [DOI] [PubMed] [Google Scholar]
  64. Lou P., Kazdan J., Bannatyne R. M., Cheung R. Successful treatment of Candida endophthalmitis with a synergistic combination of amphotericin B and rifampin. Am J Ophthalmol. 1977 Jan;83(1):12–15. doi: 10.1016/0002-9394(77)90183-0. [DOI] [PubMed] [Google Scholar]
  65. Mackenzie D. W. Studies on the morphogenesis of Candida albicans. II. Growth in organ extract. Sabouraudia. 1965 Jun;4(2):126–130. [PubMed] [Google Scholar]
  66. Mankowski Z. T. Production of glycoprotein by Candida albicans in a synthetic medium and its influence on the growth of newborn mice. Mycopathol Mycol Appl. 1968 Mar 22;34(2):113–118. doi: 10.1007/BF02051419. [DOI] [PubMed] [Google Scholar]
  67. Mardon D. N., Gunn J. L., Robinette E., Jr Variation in the lethal response in mice to yeast-like and pseudohyphal forms of Candida albicans. Can J Microbiol. 1975 Nov;21(11):1681–1687. doi: 10.1139/m75-246. [DOI] [PubMed] [Google Scholar]
  68. Martenet A. C., Wildberger H. Die Soorendophthalmitis und ihre Behandlung. Klin Monbl Augenheilkd. 1976 Jan;168(1):137–140. [PubMed] [Google Scholar]
  69. McGetrick J. J., Peyman G. A., Nyberg M. A. Amphotericin B methyl ester: evaluation for intravitreous use in experimental fungal endophthalmitis. Ophthalmic Surg. 1979 Jul;10(7):25–29. [PubMed] [Google Scholar]
  70. Meberg A., Langslet A., Sovde A., Kolstad A. Candida-septicemia with chorioretinitis, osteomyelitis and arthritis treated with systemic miconazole and intraarticular amphotericin B. Mykosen. 1977 Jul;20(7):257–260. doi: 10.1111/j.1439-0507.1977.tb01549.x. [DOI] [PubMed] [Google Scholar]
  71. Mechlinski W., Schaffner C. P. Polyene macrolide derivatives. I. N-acylation and esterification reactions with amphotericin B. J Antibiot (Tokyo) 1972 Apr;25(4):256–258. [PubMed] [Google Scholar]
  72. Medoff G., Comfort M., Kobayashi G. S. Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. Proc Soc Exp Biol Med. 1971 Nov;138(2):571–574. doi: 10.3181/00379727-138-35943. [DOI] [PubMed] [Google Scholar]
  73. Medoff G., Kobayashi G. S. Strategies in the treatment of systemic fungal infections. N Engl J Med. 1980 Jan 17;302(3):145–155. doi: 10.1056/NEJM198001173020304. [DOI] [PubMed] [Google Scholar]
  74. Meyers B. R., Lieberman T. W., Ferry A. P. Candida endophthalmitis complicating candidemia. Ann Intern Med. 1973 Nov;79(5):647–653. doi: 10.7326/0003-4819-79-5-647. [DOI] [PubMed] [Google Scholar]
  75. Michelson P. E., Rupp R., Efthimiadis B. Endogenous Candida endophthalmitis leading to bilateral corneal perforation. Am J Ophthalmol. 1975 Nov;80(5):800–803. doi: 10.1016/0002-9394(75)90274-3. [DOI] [PubMed] [Google Scholar]
  76. Monji N., Bonner D. P., Hashimoto Y., Schaffner C. P. Studies on the absorption, distribution and excretion of radioactivity after intravenous and intraperitoneal administration of 14C-methyl ester of amphotericin B. J Antibiot (Tokyo) 1975 Apr;28(4):317–324. doi: 10.7164/antibiotics.28.317. [DOI] [PubMed] [Google Scholar]
  77. Montgomerie J. Z., Edwards J. E., Jr Association of infection due to Candida albicans with intravenous hyperalimentation. J Infect Dis. 1978 Feb;137(2):197–201. doi: 10.1093/infdis/137.2.197. [DOI] [PubMed] [Google Scholar]
  78. Murray H. W., Fialk M. A., Roberts R. B. Candida arthritis. A manifestation of disseminated candidiasis. Am J Med. 1976 Apr;60(4):587–595. doi: 10.1016/0002-9343(76)90728-2. [DOI] [PubMed] [Google Scholar]
  79. Nishikawa T. The effect of cortisone acetate on the oral inoculation with Candida albicans in the germ-free mice. Keio J Med. 1969 Mar;18(1):47–57. doi: 10.2302/kjm.18.47. [DOI] [PubMed] [Google Scholar]
  80. Palmer E. A. Endogenous Candida endophthalmitis in infants. Am J Ophthalmol. 1980 Mar;89(3):388–395. doi: 10.1016/0002-9394(80)90009-4. [DOI] [PubMed] [Google Scholar]
  81. Peyman G. A., Vastine D. W., Diamond J. G. Vitrectomy in exogenous Candida endophthalmitis. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975 Oct 17;197(1):55–59. doi: 10.1007/BF00506641. [DOI] [PubMed] [Google Scholar]
  82. Piken E., Dwyer R., Zablen M. A. Gastric candidiasis. JAMA. 1978 Nov 10;240(20):2181–2182. [PubMed] [Google Scholar]
  83. Plouffe J. F., Brown D. G., Silva J., Jr, Eck T., Stricof R. L., Fekety F. R., Jr Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. Arch Intern Med. 1977 Dec;137(12):1686–1689. [PubMed] [Google Scholar]
  84. Polak A., Eschenhof E., Fernex M., Scholer H. J. Metabolic studies with 5-fluorocytosine-6-14C in mouse, rat, rabbit, dog and man. Chemotherapy. 1976;22(3-4):137–153. doi: 10.1159/000221923. [DOI] [PubMed] [Google Scholar]
  85. Price M. F., Cawson R. A. Phospholipase activity in Candida albicans. Sabouraudia. 1977 Jul;15(2):179–185. [PubMed] [Google Scholar]
  86. Pugh D., Cawson R. A. The cytochemical localization of phospholipase in Candida albicans infecting the chick chorio-allantoic membrane. Sabouraudia. 1977 Mar;15(1):29–35. [PubMed] [Google Scholar]
  87. RIMBAUD P., RIOUX J. A., BOULAD [A new localization of candidiasis: intraocular candidiasis (clinical and experimental study)]. Ann Dermatol Syphiligr (Paris) 1963 Mar-Apr;90:135–142. [PubMed] [Google Scholar]
  88. ROSENBERG S. A., DIAMOND H. D., JASLOWITZ B., CRAVER L. F. Lymphosarcoma: a review of 1269 cases. Medicine (Baltimore) 1961 Feb;40:31–84. doi: 10.1097/00005792-196102000-00002. [DOI] [PubMed] [Google Scholar]
  89. Rabinovich S., Shaw B. D., Bryant T., Donta S. T. Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice. J Infect Dis. 1974 Jul;130(1):28–31. doi: 10.1093/infdis/130.1.28. [DOI] [PubMed] [Google Scholar]
  90. Ray T. L., Wuepper K. D. Experimental cutaneous candidiasis in rodents. J Invest Dermatol. 1976 Jan;66(1):29–33. doi: 10.1111/1523-1747.ep12478053. [DOI] [PubMed] [Google Scholar]
  91. Remington J. S., Gaines J. D., Gilmer M. A. Demonstration of Candida precipitins in human sera by counterimmunoelectrophoresis. Lancet. 1972 Feb 19;1(7747):413–413. doi: 10.1016/s0140-6736(72)90860-4. [DOI] [PubMed] [Google Scholar]
  92. Rifkind D., Marchioro T. L., Schneck S. A., Hill R. B., Jr Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features. Am J Med. 1967 Jul;43(1):28–38. doi: 10.1016/0002-9343(67)90146-5. [DOI] [PubMed] [Google Scholar]
  93. Robertson D. M., Riley F. C., Hermans P. E. Endogenous Candida oculomycosis. Report of two patients treated with flucytosine. Arch Ophthalmol. 1974 Jan;91(1):33–38. doi: 10.1001/archopht.1974.03900060037009. [DOI] [PubMed] [Google Scholar]
  94. Rose H. D. Venous catheter-associated candidemia. Am J Med Sci. 1978 May-Jun;275(3):265–269. doi: 10.1097/00000441-197805000-00004. [DOI] [PubMed] [Google Scholar]
  95. Santos R., De Buen S., Juárez P. Experimental Candida albicans chorioretinitis treated by laser. Am J Ophthalmol. 1967 Mar;63(3):440–446. doi: 10.1016/0002-9394(67)90241-3. [DOI] [PubMed] [Google Scholar]
  96. Schaffner C. P., Mechlinski W. Polyene macrolide derivatives. II. Physical-chemical properties of polyene macrolide esters and their water soluble salts. J Antibiot (Tokyo) 1972 Apr;25(4):259–260. [PubMed] [Google Scholar]
  97. Schlossberg D., Devig P. M., Travers H., Kovalcik P. J., Mullen J. T. Bowel perforation with candidiasis. JAMA. 1977 Dec 5;238(23):2520–2521. [PubMed] [Google Scholar]
  98. Seelig M. S. Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses. Bacteriol Rev. 1966 Jun;30(2):442–459. doi: 10.1128/br.30.2.442-459.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Sheldon G. M., Alexander R. L. Candida endophthalmitis. Can J Ophthalmol. 1974 Jan;9(1):146–149. [PubMed] [Google Scholar]
  100. Simonetti N., Strippoli V. Pathogenicity of the Y form as compared to M form in experimentally induced Candida albicans infections. Mycopathol Mycol Appl. 1973 Sep 28;51(1):19–28. doi: 10.1007/BF02141282. [DOI] [PubMed] [Google Scholar]
  101. Sixbey J. W., Caplan E. S. Candida paropsilosis endophthalmitis. Ann Intern Med. 1978 Dec;89(6):1010–1011. doi: 10.7326/0003-4819-89-6-1010_2. [DOI] [PubMed] [Google Scholar]
  102. Smits B. J., Prior A. P., Arblaster P. G. Incidence of candida in hospital in-patients and the effects of antibiotic therapy. Br Med J. 1966 Jan 22;1(5481):208–210. doi: 10.1136/bmj.1.5481.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Snip R. C., Michels R. G. Pars plana vitrectomy in the management of endogenous Candida endophthalmitis. Am J Ophthalmol. 1976 Nov;82(5):699–704. doi: 10.1016/0002-9394(76)90005-2. [DOI] [PubMed] [Google Scholar]
  104. Sreedhara Swamy K. H., Sirsi M., Ramananda Rao G. R. Studies on the mechanism of action of miconazole: effect of miconazole on respiration and cell permeability of Candida albicans. Antimicrob Agents Chemother. 1974 Apr;5(4):420–425. doi: 10.1128/aac.5.4.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Stanley V. C., Hurley R. The growth of Candida species in cultures of mouse peritoneal macrophages. J Pathol. 1969 Feb;97(2):357–366. doi: 10.1002/path.1710970222. [DOI] [PubMed] [Google Scholar]
  106. Stern G. A., Fetkenhour C. L., O'Grady R. B. Intravitreal amphotericin B treatment of Candida endophthamitis. Arch Ophthalmol. 1977 Jan;95(1):89–93. doi: 10.1001/archopht.1977.04450010089008. [DOI] [PubMed] [Google Scholar]
  107. Stickle D., Kaufman L., Blumer S. O., McLaughlin D. W. Comparison of a newly developed latex agglutination test and an immunodiffusion test in the diagnosis of systemic candidiasis. Appl Microbiol. 1972 Mar;23(3):490–499. doi: 10.1128/am.23.3.490-499.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Sugar H. S., Mandell G. H., Shalev J. Metastatic endophthalmitis associated with injection of addictive drugs. Am J Ophthalmol. 1971 May;71(5):1055–1058. doi: 10.1016/0002-9394(71)90575-7. [DOI] [PubMed] [Google Scholar]
  109. Titsworth E., Grunberg E. Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice. Antimicrob Agents Chemother. 1973 Sep;4(3):306–308. doi: 10.1128/aac.4.3.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. VAN BUREN J. M. Septic retinitis due to Candida albicans. AMA Arch Pathol. 1958 Feb;65(2):137–146. [PubMed] [Google Scholar]
  111. Van Kirk J. E., Simon A. B., Armstrong W. R. Candida myocarditis causing complete atrioventricular block. JAMA. 1974 Feb 25;227(8):931–933. doi: 10.1001/jama.227.8.931. [DOI] [PubMed] [Google Scholar]
  112. Vastine D. W., Horsley W., Guth S. B., Goldberg M. F. Endogenous Candida endophthalmitis associated with heroin use. Arch Ophthalmol. 1976 Oct;94(10):1805–1805. doi: 10.1001/archopht.1976.03910040579023. [DOI] [PubMed] [Google Scholar]
  113. Walsh A., Haft D. A., Miller M. H., Loran M. R., Friedman A. H. Ocular penetration of 5-fluorocytosine. Invest Ophthalmol Vis Sci. 1978 Jul;17(7):691–694. [PubMed] [Google Scholar]
  114. Wellmann K. F., Reinhard A., Salazar E. P. Polyethylene catheter embolism. Review of the literature and report of a case with associated fatal tricuspid and systemic candidiasis. Circulation. 1968 Mar;37(3):380–392. doi: 10.1161/01.cir.37.3.380. [DOI] [PubMed] [Google Scholar]
  115. Wålinder P. E., Kock E. Endogenous fungus endophthalmitis. Acta Ophthalmol (Copenh) 1971;49(2):263–272. doi: 10.1111/j.1755-3768.1971.tb00950.x. [DOI] [PubMed] [Google Scholar]
  116. Yamaguchi H., Iwata K. Effect of fatty acyl group and sterol composition on sensitivity of lecithin liposomes to imidazole antimycotics. Antimicrob Agents Chemother. 1979 May;15(5):706–711. doi: 10.1128/aac.15.5.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Yonkers A. J. Candidiasis of the larynx. Ann Otol Rhinol Laryngol. 1973 Nov-Dec;82(6):812–815. doi: 10.1177/000348947308200611. [DOI] [PubMed] [Google Scholar]
  118. Young R. C., Bennett J. E., Geelhoed G. W., Levine A. S. Fungemia with compromised host resistance. A study of 70 cases. Ann Intern Med. 1974 May;80(5):605–612. doi: 10.7326/0003-4819-80-5-605. [DOI] [PubMed] [Google Scholar]
  119. Zinner S. H., Denny-Brown B. C., Braun P., Burke J. P., Toala P., Kass E. H. Risk of infection with intravenous indwelling catheters: effect of application of antibiotic ointment. J Infect Dis. 1969 Nov;120(5):616–619. doi: 10.1093/infdis/120.5.616. [DOI] [PubMed] [Google Scholar]
  120. al-Doory Y., Baker C. A. Comparative observations of ultrastructure of five species of Candida. Mycopathol Mycol Appl. 1971 Aug 6;44(4):355–367. doi: 10.1007/BF02052709. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Ophthalmological Society are provided here courtesy of American Ophthalmological Society

RESOURCES